To include your compound in the COVID-19 Resource Center, submit it here.

FDA extends comment period for companion diagnostic guidance

FDA extended the comment deadline for draft guidance on the

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE